Headache characteristics attribute to acute infections in Republic of Moldova: prospective multicentric study.

Authors

  • Cătălina GUTU Institute of Neurology and Neurosurgery “Diomid Gherman”;Nicolae Testemițanu State University of Medicine and Pharmacy
  • Mirabela MAXIMCIUC Universitatea de Stat de Medicină și Farmacie „Nicolae Testemițanu” din Republica Moldova;Clinical Hospital of Infectious Diseases “Toma Ciorbă”
  • Gabriela NACU Strășeni District Hospital
  • Galina ZOLOTCO Florești District Hospital
  • Mihaela AFANAS Universitatea de Stat de Medicină și Farmacie „Nicolae Testemițanu” din Republica Moldova;Republican Clinical Hospital “Timofei Moșneaga”
  • Oxana GROSU Institute of Neurology and Neurosurgery “Diomid Gherman”

DOI:

https://doi.org/10.52692/1857-0011.2025.3-83.23

Keywords:

headache, acute infection, INFECT-Head, chronification

Abstract

Introduction. Headache is a frequent symptom associated with acute infections; however, data regarding its characteristics and the risk of chronification remain limited, particularly outside the context of COVID-19 infection.
Materials and methods. The national cohort from the Republic of Moldova included 40 patients with headache attributed to acute infections, within the framework of the international INFECT-Head study. Evaluation was performed using a standardized questionnaire, and statistical analysis employed χ² tests, Mann-Whitney test, and logistic regression. Results. The mean age of patients was 47.4±15.5 years, with 60% being female. Current headache was severe in 72.5% of cases, predominantly bilateral, with pressing or pulsating quality, and an average duration of 8.2±7.9 hours. Common associated symptoms included vertigo (60%), photophobia (40%), and myalgia (42.5%). Headache intensity was not correlated with fever or clinical markers. Persistence beyond two weeks and intermittent evolution with attacks
were associated with an increased risk of chronification (p<0.05).

Discussion. The phenotype of post-infectious headache is heterogeneous and influenced by a history of primary headache. The identified risk factors for chronification suggest increased vulnerability in a subset of patients; however, the small sample size limits the generalizability of results.
Conclusions. Headache in acute infections shows significant clinical variability and may persist long-term. Persistence
>2 weeks and intermittent evolution may represent risk factors for chronification, highlighting the importance of careful monitoring and early intervention.

Author Biographies

Cătălina GUTU, Institute of Neurology and Neurosurgery “Diomid Gherman”;Nicolae Testemițanu State University of Medicine and Pharmacy

Resident Doctor

Mirabela MAXIMCIUC, Universitatea de Stat de Medicină și Farmacie „Nicolae Testemițanu” din Republica Moldova;Clinical Hospital of Infectious Diseases “Toma Ciorbă”

Medical Resident

Gabriela NACU, Strășeni District Hospital

Neurology Resident

Galina ZOLOTCO, Florești District Hospital

Neurology Resident

Mihaela AFANAS, Universitatea de Stat de Medicină și Farmacie „Nicolae Testemițanu” din Republica Moldova;Republican Clinical Hospital “Timofei Moșneaga”

Medical Resident

Oxana GROSU, Institute of Neurology and Neurosurgery “Diomid Gherman”

доктор медицинских наук

References

Trigo J, García-Azorín D, Sierra-Mencía Á, Tamayo- Velasco Á, Martínez-Paz P, Tamayo E, Guerrero AL, Gonzalo-Benito H. Cytokine and interleukin profile in patients with headache and COVID-19: A pilot, CASE-control, study on 104 patients. J Headache Pain. 2021 Jun 4;22(1):51.

Straburzyński M, Waliszewska-Prosół M. Comparison of headache and facial pain prevalence and phenotype in upper respiratory tract infections of differing origins - a cross-sectional study. Neurol Neurochir Pol. 2024;58(6):593-599.

García-Azorín D, Santana-López L, Lozano-Alonso JE, Ordax-Díez A, González-Osorio Y, Rojo-Rello S, Eiros JM, Sánchez-Martínez J, Recio-García A, Sierra-Mencía Á, Sanz-Muñoz I, Guerrero-Peral ÁL. InfluenCEF study: Clinical phenotype and duration of headache attributed to influenza infection. Cephalalgia. 2023 Nov;43(11):3331024231212900.

Peng KP, Wang SJ. Update of New Daily Persistent Headache. Curr Pain Headache Rep. 2022 Jan;26(1):79-84.

Mutiawati E, Kusuma HI, Fahriani M, Harapan H, Syahrul S, Musadir N. Headache in Post-COVID-19 Patients: Its Characteristics and Relationship with the Quality of Life. Medicina (Kaunas). 2022 Oct 21;58(10):1500.

Tana C, Giamberardino MA, Martelletti P. Long COVID and especially headache syndromes. Curr Opin Neurol. 2023 Jun 1;36(3):168-174.

Rueb M, Ruzicka M, Fonseca GJI, Valdinoci E, Benesch C, Pernpruner A, von Baum M, Remi J, Jebrini T, Schöberl F, Straube A, Stubbe HC, Adorjan

K. Headache severity in patients with post COVID-19 condition: a case-control study. Eur Arch Psychiatry Clin Neurosci. 2024 Dec;274(8):1935-1943.

García-Azorín D, Santana-López L, Ordax-Díez A, Lozano-Alonso JE, Macias Saint-Gerons D, González- Osorio Y, Rojo-Rello S, Eiros JM, Sánchez-Martínez J, Sierra-Mencía Á, Recio-García A, Guerrero-Peral ÁL, Sanz-Muñoz I. Incidence and prevalence of headache in influenza: A 2010-2021 surveillance-based study. Eur J Neurol. 2024 Aug;31(8):e16349.

García-Azorín D, Santana-López L, Lozano-Alonso JE, Ordax-Díez A, Vega-Alonso T, Macias Saint- Gerons D, González-Osorio Y, Rojo-Rello S, Eiros JM, Sánchez-Martínez J, Sierra-Mencía Á, Recio- García A, Martín-Toribio A, Sanz-Muñoz I, Guerrero- Peral ÁL. Factors associated to the presence of headache in patients with influenza infection and its consequences: a 2010-2020 surveillance-based study. J Headache Pain. 2024 Feb 8;25(1):18.

Published

2026-04-29

Issue

Section

Research Article

Categories